Content
10/30/2023
Palo Alto, CA USA
MapLight Therapeutics
completed $225 million Series C Round funding. Investors include
Novo Holdings (lead), 5AM Ventures, Cowen Healthcare Investments.
About
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
